Anda Repository Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANDA REPOSITORY, and what generic and branded alternatives to ANDA REPOSITORY drugs are available?
ANDA REPOSITORY has thirty-three approved drugs.
Summary for Anda Repository
| US Patents: | 0 |
| Tradenames: | 28 |
| Ingredients: | 28 |
| NDAs: | 33 |
Drugs and US Patents for Anda Repository
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anda Repository | CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065429-002 | Jul 18, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Anda Repository | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 088729-001 | Apr 11, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Anda Repository | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 089259-001 | May 5, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
